BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/27/2015 6:30:00 PM | Browse: 1048 | Download: 1495
Publication Name World Journal of Clinical Cases
Manuscript ID 17451
Country/Territory
Received
2015-03-08 14:52
Peer-Review Started
2015-03-08 15:17
To Make the First Decision
2015-03-20 14:34
Return for Revision
2015-03-28 17:57
Revised
2015-04-17 21:17
Second Decision
2015-05-07 09:57
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2015-05-18 17:06
Articles in Press
2015-05-18 17:06
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-07-07 19:10
Publish the Manuscript Online
2015-07-27 18:31
ISSN 2307-8960 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Surgery
Manuscript Type Minireviews
Article Title How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer
Manuscript Source Invited Manuscript
All Author List Elissa R Price, Jasmine Wong, Rita Mukhtar, Nola Hylton and Laura J Esserman
Funding Agency and Grant Number
Corresponding Author Elissa R Price, Assistant Professor, Department of Radiology and Biomedical Imaging, University of California, 1600 Divisadero Street, Room C-250, San Francisco, CA 94115, United States. elissa.price@ucsf.edu
Key Words Breast; Magnetic resonance imaging; Neoadjuvant chemotherapy; Biomarkers; Phenotypes
Core Tip Following neoadjuvant chemotherapy, breast magnetic resonance imaging (MRI) most accurately predicts surgical pathology in triple negative, Her2 positive and hormone receptor negative tumors, especially if they are of a solid imaging phenotype. In these cases, post-neoadjuvant chemotherapy (NAC) MRI is highly reliable for surgical planning. Hormone receptor positive cancers and those demonstrating non mass enhancement show lower concordance with surgical pathology, making surgical guidance more nebulous in these cases. Radiologists and surgeons must assess MRI response to NAC in the context of tumor subtype.
Publish Date 2015-07-27 18:31
Citation Price ER, Wong J, Mukhtar R, Hylton N, Esserman LJ. How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer. World J Clin Cases 2015; 3(7): 607-613
URL http://www.wjgnet.com/2307-8960/full/v3/i7/607.htm
DOI http://dx.doi.org/10.12998/wjcc.v3.i7.607
Full Article (PDF) WJCC-3-607.pdf
Full Article (Word) WJCC-3-607.doc
Manuscript File 17451-Review.docx
Answering Reviewers 17451-Answering reviewers.pdf
Audio Core Tip 17451-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 17451-Conflict-of-interest statement.pdf
Copyright License Agreement 17451-Copyright assignment.pdf
Peer-review Report 17451-Peer-review(s).pdf
Scientific Misconduct Check 17451-Scientific misconduct check.pdf
Scientific Editor Work List 17451-Scientific editor work list.pdf